Lamictal Dispersible
Lamotrigine dispersible tablets for bipolar I disorder and epilepsy. They dissolve in water, making them easier to swallow.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 50mg | 30 tablets | $93.00 | $3.10 |
| 50mg | 60 tablets | $179.00 | $2.98 |
| 50mg | 100 tablets | $278.00 | $2.78 |
| 100mg | 30 tablets | $97.00 | $3.23 |
| 100mg | 60 tablets | $182.00 | $3.03 |
| 100mg | 100 tablets | $258.00 | $2.58 |
- Category
- Mental Health
- Active ingredient
- Lamotrigine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg · 100mg
No prescription needed: we place your order for Lamictal Dispersible on your behalf.
Lamictal Dispersible details
- Conditions
- Bipolar I Disorder · Epilepsy
- Alternative names
- lamotrigine
- Therapeutic class
- Antiepileptic Agent; Phenyltriazine Derivative
- Pharmacological class
- Anticonvulsant, Phenyltriazine Derivative
- Contraindications
- hypersensitivity to lamotrigine
- Minor side effects
- dizziness; headache; drowsiness
- Moderate side effects
- rash; insomnia; nausea
- Dosage forms
- Tablet
- Administration route
- Oral use
- Manufacturer
- GlaxoSmithKline
- Onset time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Valproic Acid; Oral Contraceptives; Phenytoin
- Age restrictions
- Approved for children and adults.
Serious side effects
Stevens-Johnson syndrome, requires immediate medical attention; toxic epidermal necrolysis, requires immediate medical attention
Patient summary
Lamotrigine dispersible tablets for bipolar I disorder and epilepsy. They dissolve in water, making them easier to swallow.
Mechanism of action
Dissolves rapidly for easy administration, blocking voltage-gated sodium pathways to prevent excitatory neural communication.
Pregnancy and breastfeeding
Pregnancy: Suitability during pregnancy depends on the specific medicine and individual circumstances. Confirm with a qualified clinician or pharmacist before use. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.